Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction

Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction

US Patent 8653051 · Granted Feb 18, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Drug delivery system2021
Pharmaceutical formulations and uses thereof in the treatment of female sexual d2019
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction2019
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction2019
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction2019
Drug delivery system2017
Pharmaceutical formulations and uses thereof in the treatment of female sexual d2017
Pharmaceutical formulations and uses thereof in the treatment of female sexual d2017
Pharmaceutical formulations and uses thereof in the treatment of female sexual d2017
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction2017
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction2017
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction2017